http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021277485-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a5e5321c40444c402ceb19ef2f43de6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2019-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_497dc91437cb13063c5d0ec7b717a3d1 |
| publicationDate | 2021-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021277485-A1 |
| titleOfInvention | Method for prognosis of colorectal cancer |
| abstract | The invention relates to the prognosis of colorectal cancer, especially left-sided (distal) colorectal cancer. The invention provides an assay method for selecting patients suffering from colorectal cancer for different prognostic groups, the method comprising the steps of detecting mutations in expressed KRAS mRNA and selecting the prognostic group of said patient, wherein the presence or increased level of a mutation in expressed KRAS mRNA indicates that the patient having a left-sided colorectal cancer has a worse prognosis than in the absence of a mutation in expressed KRAS mRNA. |
| priorityDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.